Rchr
J-GLOBAL ID:201801012431591045   Update date: Apr. 05, 2024

Hippo Yoshitaka

ヒッポウ ヨシタカ | Hippo Yoshitaka
Affiliation and department:
Research field  (1): Tumor biology
Research theme for competitive and other funds  (26):
  • 2023 - 2026 Elucidation of MYCN/NCYM function in outer radial glial cell
  • 2023 - 2026 Usefulness of ORF dominance as a novel biomarker in cholangiopancreatic cancer
  • 2022 - 2025 Elucidation of the mechanisms underlying drug-resistance and development of predictive biomarker using patient-derived ovarian cancer organoids
  • 2022 - 2025 Elucidation of the mechanisms underlying drug-resistance and development of therapeutic strategy of refractory cervical cancer using patient-derived organoids
  • 2021 - 2024 Elucidation of genetic interactions underlying tumor development and metastasis using murine endometrial organoids
Show all
Papers (66):
  • Yoshiaki Maru, Mami Kohno, Kiyomi Suzuka, Akiko Odaka, Mari Masuda, Akinobu Araki, Makiko Itami, Naotake Tanaka, Yoshitaka Hippo. Establishment and characterization of multiple patient-derived organoids from a case of advanced endometrial cancer. Human cell. 2024
  • Kazuma Nakatani, Hiroyuki Kogashi, Takanori Miyamoto, Taiki Setoguchi, Tetsushi Sakuma, Kazuto Kugou, Yoshinori Hasegawa, Takashi Yamamoto, Yoshitaka Hippo, Yusuke Suenaga. Inhibition of OCT4 binding at the MYCN locus induces neuroblastoma cell death accompanied by downregulation of transcripts with high-open reading frame dominance. Frontiers in oncology. 2024. 14. 1237378-1237378
  • Yusuke Toyohara, Ayumi Taguchi, Yoshiyuki Ishii, Daisuke Yoshimoto, Miki Yamazaki, Hiroko Matsunaga, Kazuma Nakatani, Daisuke Hoshi, Saki Tsuchimochi, Misako Kusakabe, et al. Identification of target cells of human papillomavirus 18 using squamocolumnar junction organoids. Cancer science. 2023
  • Jihang Yao, Keizo Takenaga, Nobuko Koshikawa, Yuki Kida, Jason Lin, Takayoshi Watanabe, Yoshiaki Maru, Yoshitaka Hippo, Seigi Yamamoto, Yuyan Zhu, et al. Anticancer effect of a pyrrole-imidazole polyamide-triphenylphosphonium conjugate selectively targeting a common mitochondrial DNA cancer risk variant in cervical cancer cells. International journal of cancer. 2023. 152. 5. 962-976
  • Misako Kusakabe, Ayumi Taguchi, Michihiro Tanikawa, Daisuke Hoshi, Saki Tsuchimochi, Xi Qian, Yusuke Toyohara, Akira Kawata, Ryota Wagatsuma, Kohei Yamaguchi, et al. Application of organoid culture from HPV18-positive small cell carcinoma of the uterine cervix for precision medicine. Cancer medicine. 2023. 12. 7. 8476-8489
more...
MISC (154):
  • 井本義則, 高山亘, 大坂美穗, 永瀬浩喜, 高取敦志, 冨樫庸介, 筆宝義隆, 若林雄一, 三上春夫, 下里修, et al. 千葉県がんセンター年報(令和2年度). 千葉県がんセンター年報. 2022. 48
  • 喜多絵美里, 丸喜明, 筆宝義隆. ヒト膵液由来オルガノイドを用いたIPMNモデルの構築と分化に関する検討. 日本消化器病学会雑誌(Web). 2022. 119
  • 筆宝義隆. オルガノイド培養技術の婦人科がん領域への応用. 日本再生医療学会総会(Web). 2021. 20th
  • 丸喜明, 筆宝義隆. オルガノイドex vivo発がんモデルを用いた卵管上皮の発がん促進的な遺伝的相互作用の包括的検証. 日本癌学会学術総会抄録集(Web). 2021. 80th
  • 瀬戸口大毅, 瀬戸口大毅, 星大輔, 中谷一真, 古樫浩之, 井内俊彦, 筆宝義隆, 末永雄介. モネンシンによる膠芽腫の細胞死はp53/PIDD/Caspase2経路の活性化を介する. 日本癌学会学術総会抄録集(Web). 2021. 80th
more...
Books (1):
  • 癌における転写ネットワーク変異の体系的解明
    油谷浩幸 2009
Education (2):
  • 1996 - 2000 The University of Tokyo Graduate School of Medicine
  • 1988 - 1994 The University of Tokyo Faculty of Medicine School of Medicine
Work history (6):
  • 2022/07 - 現在 Chiba Cancer Center
  • 2019/04 - 現在 Chiba University Graduate School of Medicine
  • 2014/09 - 2022/06 Chiba Cancer Center
  • 2009/01 - 2014/08 国立がんセンター研究所 早期がん研究プロジェクト 室長
  • 2005/04 - 2008/12 コールドスプリングハーバー研究所 博士研究員
Show all
Committee career (8):
  • 2022/01 - 現在 Cancer Science Associate Editor
  • 2021/05 - 現在 日本がん分子標的治療学会 評議員
  • 2020/09 - 現在 公益財団法人 環境科学技術研究所 評価委員
  • 2017/04 - 現在 日本癌学会 評議員
  • 2018/01 - 2021/12 日本癌学会 広報委員
Show all
Association Membership(s) (3):
THE JAPANESE ASSOCIATION FOR MOLECULAR TARGET THERAPY OF CANCER ,  THE JAPANESE CANCER ASSOCIATION ,  日本がん転移学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page